SHANGHAI ZJ BIO-TECH CO., LTD Financials Shanghai ZJ Bio-Tech Co., Ltd
Equities
688317
CNE100005DB6
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.35 CNY | +0.06% |
|
+0.74% | -22.07% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 10,055 | 6,418 | 4,031 |
| Enterprise Value (EV) 1 | 7,119 | 3,279 | 1,269 |
| P/E ratio | 13 x | 8.5 x | -29.5 x |
| Yield | 2.64% | 3.59% | - |
| Capitalization / Revenue | 4.98 x | 2.76 x | 14.7 x |
| EV / Revenue | 3.53 x | 1.41 x | 4.63 x |
| EV / EBITDA | 7.96 x | 4.15 x | -6.4 x |
| EV / FCF | -49.2 x | 7.97 x | -12.8 x |
| FCF Yield | -2.03% | 12.5% | -7.79% |
| Price to Book | 2.63 x | 1.53 x | 1.05 x |
| Nbr of stocks (in thousands) | 194,704 | 192,158 | 192,158 |
| Reference price 2 | 51.64 | 33.40 | 20.98 |
| Announcement Date | 4/21/22 | 4/20/23 | 4/21/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 224.4 | 258.9 | 2,052 | 2,019 | 2,326 | 274.3 |
| EBITDA 1 | 91.43 | 72.83 | 1,150 | 894.2 | 790.8 | -198.2 |
| EBIT 1 | 69.61 | 50.27 | 1,131 | 869.8 | 733.8 | -261.1 |
| Operating Margin | 31.03% | 19.42% | 55.09% | 43.08% | 31.54% | -95.17% |
| Earnings before Tax (EBT) 1 | 69.77 | 61.03 | 1,109 | 896.4 | 901.5 | -156.6 |
| Net income 1 | 59.67 | 51.52 | 932 | 758.5 | 760.3 | -136.9 |
| Net margin | 26.6% | 19.9% | 45.42% | 37.57% | 32.68% | -49.89% |
| EPS 2 | 0.4100 | 0.3500 | 6.380 | 3.980 | 3.930 | -0.7100 |
| Free Cash Flow 1 | 46.67 | 26.83 | 759.5 | -144.7 | 411.3 | -98.85 |
| FCF margin | 20.8% | 10.37% | 37.01% | -7.17% | 17.68% | -36.03% |
| FCF Conversion (EBITDA) | 51.05% | 36.84% | 66.04% | - | 52.02% | - |
| FCF Conversion (Net income) | 78.22% | 52.08% | 81.49% | - | 54.1% | - |
| Dividend per Share | - | 0.9000 | 1.600 | 1.365 | 1.200 | - |
| Announcement Date | 6/25/19 | 5/21/20 | 4/21/21 | 4/21/22 | 4/20/23 | 4/21/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 266 | 246 | 1,205 | 2,936 | 3,139 | 2,762 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 46.7 | 26.8 | 760 | -145 | 411 | -98.8 |
| ROE (net income / shareholders' equity) | 11.8% | 9.33% | 91.6% | 28.7% | 18.9% | -3.41% |
| ROA (Net income/ Total Assets) | 7.94% | 5.14% | 56% | 17.7% | 10.2% | -3.7% |
| Assets 1 | 751.6 | 1,002 | 1,663 | 4,280 | 7,458 | 3,698 |
| Book Value Per Share 2 | 3.810 | 3.920 | 10.00 | 19.70 | 21.90 | 19.90 |
| Cash Flow per Share 2 | 1.900 | 1.690 | 8.250 | 15.10 | 16.40 | 14.40 |
| Capex 1 | 17.5 | 23.6 | 74.6 | 498 | 74.6 | 81.1 |
| Capex / Sales | 7.79% | 9.1% | 3.63% | 24.67% | 3.21% | 29.58% |
| Announcement Date | 6/25/19 | 5/21/20 | 4/21/21 | 4/21/22 | 4/20/23 | 4/21/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -22.07% | 434M | |
| -5.27% | 12.23B | |
| -3.86% | 8.17B | |
| +33.66% | 5.74B | |
| -7.35% | 4.24B | |
| -55.63% | 2.97B | |
| +13.62% | 2.73B | |
| -3.65% | 2.38B | |
| +30.67% | 2.26B | |
| -4.31% | 1.87B |
- Stock Market
- Equities
- 688317 Stock
- Financials Shanghai ZJ Bio-Tech Co., Ltd